Market Cap : 436.89 M | Enterprise Value : 144.46 M | PE Ratio : At Loss | PB Ratio : |
---|
NAS:HLVX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:HLVX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2022-08-17), HilleVax's 14-Day RSI is 53.33.
The industry rank for HilleVax's 14-Day RSI or its related term are showing as below:
HLVX's 14-Day RSI is ranked worse thanFor the Biotechnology subindustry, HilleVax's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, HilleVax's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where HilleVax's 14-Day RSI falls into.
The formula for calculating RSI is:
RSI | = | 100 | – | [ 100 | / | ( 1 + Average Gain | / | Average Loss )] |
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Thank you for viewing the detailed overview of HilleVax's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.
Fhmls X, L.l.c. | 10 percent owner | 601 UNION STREET, SUITE 3200 TWO UNION SQUARE SEATTLE WA 98101 |
Dubin Gary | director | C/O HILLEVAX, INC. 75 STATE STREET, SUITE 100 - #9995 BOSTON MA 02109 |
Borkowski Astrid | officer: Chief Medical Officer | C/O HILLEVAX, INC. 75 STATE STREET, SUITE 100 - #9995 BOSTON MA 02109 |
Sepulveda Jaime | director | C/O HILLEVAX INC. 75 STATE STREET 100 - #9995 BOSTON MA 02109 |
Takeda Vaccines, Inc. | 10 percent owner | 75 SIDNEY STREET CAMBRIDGE MA 02139 |
Chu Shelley | director | ONE WINTHROP SQUARE SUITE 400 BOSTON MA 02110 |
Silbermann Susan Michele | director | C/O LIANBIO 103 CARNEGIE CENTER DRIVE, SUITE 215 PRINCETON NJ 08540 |
Fhmls X, L.p. | 10 percent owner | 601 UNION STREET, SUITE 3200 TWO UNION SQUARE SEATTLE WA 98101 |
Frazier Life Sciences X, L.p. | 10 percent owner | 601 UNION STREET, SUITE 3200 TWO UNION SQUARE SEATTLE WA 98101 |
Gerberding Julie L. | director | 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Kohli Aditya | director, officer: Chief Operating Officer | C/O PHATHOM PHARMACEUTICALS, INC. 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089 |
Socks David A | officer: CFO & Chief Business Officer | C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 |
Takeda Pharmaceutical Co Ltd | 10 percent owner | 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 |
Hershberg Robert | director, officer: President and CEO | 3005 FIRST AVENUE SEATTLE WA 98121 |
Topper James N | 10 percent owner | 550 HAMILTON AVENUE, SUITE 100 PALO ALTO CA 94301 |
From GuruFocus
Other Sources
By tipranks.com 2022-05-25